Kharazmi Pharmaceutical Company
Kharazmi Pharmaceutical Company is a privately held pharmaceutical manufacturer founded in 1963 and based in Tehran, Iran. It produces oral, topical and paediatric medicines as well as vitamin and nutritional supplement products. Its Tehran production site and affiliations spanning distribution, chemical, plasma and oncology-oriented activities make it relevant to domestic pharmaceutical sourcing and healthcare supply-chain partnerships.
Operations & footprint
Products and services
Kharazmi Pharmaceutical Company manufactures pharmaceutical products including tablets, capsules, syrups, oral drops, oral antibiotics, creams, sprays, dermatology products, pediatric medicines, gastrointestinal products, respiratory medicines, supplements, and selected specialty pharmaceutical items. Its group links include pharmaceutical distribution, plasma-related activity, oncology-oriented development, and broader healthcare supply functions.
Operations and assets
The Tehran facility covers 17,000 sq m, including a 7,000 sq m production area across two floors. Manufacturing formats include tablets, capsules, syrups, oral drops, oral antibiotics, creams and sprays.
Geographic footprint
Tehran, Iran.
Ownership & group structure
Subsidiaries and group companies
Group affiliations include Eltiam Distribution Company, Parto Chemii Company, Kharazmi Bio Onco Company and Kharazmi Plasma Company.
Reported scale
Employees: 49 employees as of 2023.
Commercial and investment relevance
Kharazmi Pharmaceutical is relevant for investors assessing Iran's private generic-drug manufacturing base, domestic medicine supply, pediatric and oral-dosage demand, distribution-linked business models, and import substitution in active ingredients and packaging. It can support analysis of how older pharmaceutical manufacturers adapt through group structures, distribution arms, and specialty-drug initiatives. Due diligence should verify legal ownership, factory location, product registrations, GMP compliance, sister-company relationships, API sourcing, export markets, distributor dependence, receivables, working capital, and whether any group entity has separate disclosure or financing obligations. The company supplies a broad finished-dose portfolio spanning common medicines, paediatric formulations, topical products and supplements. Its affiliated distribution and healthcare companies make it relevant to buyers and suppliers seeking access to domestic pharmaceutical manufacturing and route-to-market relationships in Iran.
Constraints, risk & compliance
Key risks and constraints
Commercial performance depends on maintaining quality-system compliance across multiple finished-dose formats and on reliable supply of pharmaceutical inputs and packaging for a broad product portfolio.
Need more than a public profile?
Ask Hormuz to investigate, verify or act locally around Kharazmi Pharmaceutical Company. Tell us exactly what you need.
Connected Intelligence
Relevant geography, industry, market and execution context for this profile.
Frequently asked questions
Direct answers to the questions most likely to arise when reviewing this profile.
What does Kharazmi Pharmaceutical Company manufacture?
The company manufactures tablets, capsules, syrups, oral drops, oral antibiotics, creams and sprays, including prescription medicines, paediatric products, topical treatments and nutritional supplements.
Where is Kharazmi Pharmaceutical Company located?
Its headquarters and production site are in Tehran, Iran, at Kilometre 9 of Karaj Special Road in Esteghlal Town.
When was Kharazmi Pharmaceutical Company founded?
Kharazmi Pharmaceutical Company was founded in 1963. It began operations under the name Max Darmer before adopting its current name.
What operating assets does Kharazmi Pharmaceutical Company have?
The company operates a 17,000 sq m Tehran site, with a 7,000 sq m production area arranged over two floors.